Therapeutic drug monitoring of thiopurine metabolites in adult thiopurine tolerant IBD patients on maintenance therapy-Reference-Cited by-同舟云学术

Therapeutic drug monitoring of thiopurine metabolites in adult thiopurine tolerant IBD patients on maintenance therapy

Published:2012-07 Issue:6 Volume:6 Page:698-707
ISSN:1873-9946
Container-title:Journal of Crohn's and Colitis
language:en
Short-container-title:Journal of Crohn's and Colitis

Author:

Gilissen Lennard P.L.,Wong Dennis R.,Engels Leopold G.J.B.,Bierau Jörgen,Bakker Jaap A.,Paulussen Aimée D.C.,Romberg-Camps Mariëlle J.,Stronkhorst Arnold,Bus Paul,Bos Laurens P.,Hooymans Piet M.,Stockbrügger Reinhold W.,Neef Cees,Masclee Ad A.M.

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,General Medicine

Link

http://academic.oup.com/ecco-jcc/article-pdf/6/6/698/1083977/6-6-698.pdf

Reference45 articles.

1. Pharmacogenetics of thiopurines in inflammatory bowel disease;Derijks;Curr Pharm Des,2010

2. Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity;Weinshilboum;Am J Hum Genet,1980

3. Genetic polymorphism of thiopurine S-methyltransferase: molecular mechanisms and clinical importance;Krynetski;Pharmacology,2000

4. TPMT in the treatment of Crohn's disease with azathioprine;Lennard;Gut,2002

5. Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease;Dubinsky;Gastroenterology,2000

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Pharmacogenetics in the Therapeutic Response to Thiopurines in the Treatment of Inflammatory Bowel Disease: A Systematic Review;Journal of Clinical Medicine;2023-10-25

2. Personalizing therapy selection in inflammatory bowel disease;Expert Review of Clinical Immunology;2023-04-03

3. Updates on conventional therapies for inflammatory bowel diseases: 5-aminosalicylates, corticosteroids, immunomodulators, and anti-TNF-α;The Korean Journal of Internal Medicine;2022-09-01

4. Cytotoxicity of Thiopurine Drugs in Patients with Inflammatory Bowel Disease;Toxics;2022-03-22

5. Current status and future perspectives on the use of therapeutic drug monitoring of thiopurine metabolites in patients with inflammatory bowel disease;Expert Opinion on Drug Metabolism & Toxicology;2021-12-02